Across TCGA pan-cancer cohorts, LINC02534 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated LINC02534 data layer.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC02534 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02534 expression acts as an unfavorable survival marker.
KIRC and COAD are the cancer types where LINC02534 RNA most reproducibly stratifies survival.